Recent advances in pharmacotherapy of renal cell carcinoma

A tétel rövid nézete
dc.contributor.advisorMegyeri, Attila
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.authorAshraf, Aneea
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmikósi, József András
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Aneszteziológiai és Intenzív Terápiás Tanszék
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.date.accessioned2023-05-09T12:02:32Z
dc.date.available2023-05-09T12:02:32Z
dc.date.created2023-02-28
dc.description.abstractRenal cell carcinoma is one of the most malignant urogenital cancers. Its prevalence has been on the rise recently, perhaps at least partly as a result of changing lifestyles. Its histological subtypes, risk factors, and many signalling pathways involved in tumorigenesis are covered in the first part of this thesis. Renal cell carcinoma can be treated with several pharmacological tools that are reviewed along with their mechanism of action, pharmacokinetics, and side effects. One of the more effective strategies for treating advanced renal cell cancer may be the combination of medicines targeting the vascular endothelial growth factor -pathway. Bevacizumab, a monoclonal antibody inhibitor of vascular endothelial growth factor thus an inhibitor of angiogenesis and endothelial cell proliferation, served as a proof of concept for anti-angiogenic therapy and may provide further advantages when used in combination with other medications.
dc.description.correctorLB
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent55
dc.identifier.urihttps://hdl.handle.net/2437/352430
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectcancer
dc.subjecttherapy
dc.subjectrenal cell carcinoma
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológia
dc.titleRecent advances in pharmacotherapy of renal cell carcinoma
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)